Salwa
Impact in
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 10
- Drug Solubulity and Delivery Systems 5
- Advancements in Transdermal Drug Delivery 5
-
- Nanoparticle-Based Drug Delivery 7
- Co-authors
- Lalit Kumar (20 shared papers)Srinivas Reddy Jitta (8 shared papers)Navya Ajitkumar Bhaskaran (7 shared papers)Shirleen Miriam Marques (6 shared papers)Ruchi Verma (6 shared papers)Ben Zhong Tang (1 shared paper)Vivek P. Chavda (1 shared paper)Anjali Pandya (1 shared paper)
- Journals
- Journal of Drug Delivery Science and Technology (2 papers)Journal of Pharmaceutical Innovation (2 papers)International Journal of Biological Macromolecules (2 papers)Sustainable Chemistry and Pharmacy (1 paper)Journal of Controlled Release (1 paper)
- Partner nations
- IndiaUnited StatesChina
In The Last Decade
Salwa
21 papers receiving 435 citations
Peers
Comparison fields: 5 of 58
- Pharmaceutical Science 166
- Biomaterials 107
- Analytical Chemistry 58
- Drug Discovery 1
- Molecular Biology 94
Countries citing papers authored by Salwa
This map shows the geographic impact of Salwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salwa more than expected).
Fields of papers citing papers by Salwa
This network shows the impact of papers produced by Salwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salwa. The network helps show where Salwa may publish in the future.
Co-authors
The 21 scholars most cited alongside Salwa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 123 | |
| 2 | 2021 | 45 | |
| 3 | 2022 | 41 | |
| 4 | 2023 | 32 | |
| 5 | 2019 | 27 | |
| 6 | 2023 | 27 | |
| 7 | 2021 | 26 | |
| 8 | 2022 | 19 | |
| 9 | 2021 | 14 | |
| 10 | 2023 | 14 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 13 | |
| 13 | 2023 | 10 | |
| 14 | 2025 | 10 | |
| 15 | 2022 | 9 | |
| 16 | 2023 | 9 | |
| 17 | 2023 | 7 | |
| 18 | 2024 | 7 | |
| 19 | 2023 | 3 | |
| 20 | 2022 | 2 |
About Salwa
Salwa is a scholar working on Pharmaceutical Science, Biomaterials, Analytical Chemistry, Developmental Neuroscience and Infectious Diseases, having authored 21 papers that have together received 452 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (10 papers), Nanoparticle-Based Drug Delivery (7 papers), Drug Solubulity and Delivery Systems (5 papers), Advancements in Transdermal Drug Delivery (5 papers), Analytical Methods in Pharmaceuticals (3 papers), Pluripotent Stem Cells Research (1 paper), Alzheimer's disease research and treatments (1 paper) and Antifungal resistance and susceptibility (1 paper). The work is most often cited by research in Pharmaceutical Science (166 citations), Biomaterials (107 citations), Analytical Chemistry (58 citations), Drug Discovery (1 citation) and Molecular Biology (94 citations). Salwa has collaborated with scholars based in India, United States and China. Frequent co-authors include Lalit Kumar, Srinivas Reddy Jitta, Navya Ajitkumar Bhaskaran, Shirleen Miriam Marques, Ruchi Verma, Ben Zhong Tang, Vivek P. Chavda, Anjali Pandya, Nidhi Raval and Lalitkumar K. Vora. Their work appears in journals such as Journal of Drug Delivery Science and Technology, Journal of Pharmaceutical Innovation, International Journal of Biological Macromolecules, Sustainable Chemistry and Pharmacy and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.